Page 6 - Decoy Biosystems Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Lifshitz Law Firm, P C Announces Investigation of STAY, FI, GNMK, NTEC, RMBL, and SLGG

Lifshitz Law Firm, P C Announces Investigation of STAY, FI, GNMK, NTEC, RMBL, and SLGG
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesJoshua lifshitzJoshuam lifshitzSuper leagueStarwood capital groupSuper league gaming incExpro groupGenmark diagnostics incRumbleon incLifshitz law firmIntec pharma ltdStay america incDecoy biosystems incFrank internationalStay america

INTEC PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Intec Pharma Ltd

Press release content from Business Wire. The AP news staff was not involved in its creation. INTEC PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Intec Pharma Ltd. - NTEC March 17, 2021 GMT NEW ORLEANS (BUSINESS WIRE) Mar 17, 2021 Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Intec Pharma Ltd. (“the Company”) (NasdaqCM: NTEC) to Decoy Biosystems, Inc. pursuant to which Intec shareholders are expected to only own approximately 25% of the combined company, on a fully diluted basis. KSF is seeking to determine whether the merger and the process that led to it are adequate, or whether the merger undervalues the Company.

United statesLewiss kahnCharlesc foti jrCompany nasdaqIntec pharma ltdDecoy biosystems incKahn swick fotiAttorney generalLouisiana charlesKahn swickWintec pharmaDecoy biosystemsPartner lewisFormer louisiana attorney generalManaging partnerBusiness wire

INVESTIGATION ALERT: Halper Sadeh LLP Investigates STAY, GNMK, RMBL, FI, NTEC; Shareholders are Encouraged to Contact the Firm

/PRNewswire/ Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Extended Stay America, Inc..

United statesDaniel sadehZachary halperHalper sadehStarwood capital groupExpro groupGenmark diagnostics incRumbleon incIntec pharma ltdStay america incDecoy biosystems incFrank internationalStay americaBlackstone real estate partnersExtended stayMark diagnostics

Intec Pharma and Decoy Biosystems Announce Merger Agreement

Intec Pharma and Decoy Biosystems Announce Merger Agreement USA - English Investigational New Drug Application Filing Expected in 2H 2021 News provided by Share this article Share this article JERUSALEM, March 15, 2021 /PRNewswire/ Intec Pharma Ltd. (NASDAQ: NTEC) ( Intec or the Company ) announced today that it has entered into a definitive agreement for a business combination with Decoy Biosystems, Inc., a privately-held, preclinical-stage biotechnology company developing novel, multi-targeted products that safely prime both innate and adaptive anti-tumor and anti-viral immune responses. The combined company will advance its immunotherapy platform to battle a variety of tumor types and chronic viral infections. Decoy previously held a pre-IND meeting with the FDA, currently plans to file an IND in the second half of 2021 and to initiate a Phase I clinical trial in 2022 targeting solid tumors and lymphomas.

Israel generalSan diegoUnited statesWintec pharmaRoger pomerantzHar hotzvimMichaelj newmanJeffreya mecklerPrnewswire intec pharma ltdIntec pharma ltdCompany current report on formDecoy biosystems incCompany accordion pillDecoy biosystemsVice chairmanChief executive officer

Best Penny Stocks To Buy Now? 5 For Your Watch List

Best Penny Stocks To Buy Now? 5 For Your Watch List
dailyherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailyherald.com Daily Mail and Mail on Sunday newspapers.

United statesSanjays shuklaWintec pharmaAlex ovadiaRobert cohenJames sapirsteinJeffreya mecklerPpd incZomedica corpFederal reserveAtyr pharma incAmerican association for cancer researchCap ltdDecoy biosystems incAzurrx biopharma incMaxim group emerging growth conference